GlassScriptPhysician profile
Latavia S Esters
NPI 1619157831
$4,285.41
in general payments reported to CMS, 2019-2025
12 companies · $1,533 in 2025
The $1,533 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $459 · 2024: $1,637 · 2025: $1,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043 · Travel and Lodging: $1,082 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.79 |
| Travel and Lodging | $1,081.67 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,545.03 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Nalu Medical, INC. | $1,091.62 | 2024-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $828.00 | 2021-2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $378.75 | 2021-2025 | Relistor |
| Biotronik Nro, INC. | $187.97 | 2024-2025 | Prospera |
| Forte Bio-Pharma LLC | $103.57 | 2021-2025 | Prolate, Tanlor, Nalocet |
| Vertex Pharmaceuticals Incorporated | $46.27 | 2025 | |
| Vertos Medical, INC. | $29.41 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $24.14 | 2025 | |
| Mml US, INC. | $20.84 | 2025 | Reactiv8 |
| Globus Medical, INC. | $15.22 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $14.59 | 2024 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latavia Esters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.